- Home
- SXC vs SVRA Comparison
SXC vs SVRA Comparison
Compare SXC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXC
- SVRA
- Stock Information
- Founded
- SXC 1960
- SVRA 2007
- Country
- SXC United States
- SVRA United States
- Employees
- SXC N/A
- SVRA N/A
- Industry
- SXC Steel/Iron Ore
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SXC Industrials
- SVRA Health Care
- Exchange
- SXC Nasdaq
- SVRA Nasdaq
- Market Cap
- SXC 653.6M
- SVRA 527.2M
- IPO Year
- SXC N/A
- SVRA N/A
- Fundamental
- Price
- SXC $7.72
- SVRA $3.65
- Analyst Decision
- SXC Strong Buy
- SVRA Buy
- Analyst Count
- SXC 1
- SVRA 8
- Target Price
- SXC $13.00
- SVRA $6.63
- AVG Volume (30 Days)
- SXC 938.3K
- SVRA 1.9M
- Earning Date
- SXC 10-30-2025
- SVRA 08-13-2025
- Dividend Yield
- SXC 6.18%
- SVRA N/A
- EPS Growth
- SXC 15.74
- SVRA N/A
- EPS
- SXC 0.85
- SVRA N/A
- Revenue
- SXC $1,846,200,000.00
- SVRA N/A
- Revenue This Year
- SXC N/A
- SVRA N/A
- Revenue Next Year
- SXC N/A
- SVRA N/A
- P/E Ratio
- SXC $9.15
- SVRA N/A
- Revenue Growth
- SXC N/A
- SVRA N/A
- 52 Week Low
- SXC $7.18
- SVRA $1.89
- 52 Week High
- SXC $12.82
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- SXC 51.13
- SVRA 67.60
- Support Level
- SXC $7.53
- SVRA $3.70
- Resistance Level
- SXC $7.83
- SVRA $3.92
- Average True Range (ATR)
- SXC 0.19
- SVRA 0.19
- MACD
- SXC 0.04
- SVRA 0.01
- Stochastic Oscillator
- SXC 72.22
- SVRA 65.12
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.